• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢综合征与肾脏介入治疗后的结局。

Metabolic syndrome and outcomes after renal intervention.

机构信息

Department of Cardiovascular Surgery, Methodist DeBakey Heart and Vascular Center, The Methodist Hospital, 6550 Fannin, Smith Tower, Suite 1401, Houston, TX 77030, USA.

出版信息

Cardiol Res Pract. 2010 Dec 27;2011:781035. doi: 10.4061/2011/781035.

DOI:10.4061/2011/781035
PMID:21234418
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3014711/
Abstract

Metabolic syndrome significantly increases the risk for cardiovascular disease and chronic kidney disease. The increased risk for cardiovascular diseases can partly be caused by a prothrombotic state that exists because of abdominal obesity. Multiple observational studies have consistently shown that increased body mass index as well as insulin resistance and increased fasting insulin levels is associated with chronic kidney disease, even after adjustment for related disorders. Metabolic syndrome appears to be a risk factor for chronic kidney disease, likely due to the combination of dysglycemia and high blood pressure. Metabolic syndrome is associated with markedly reduced renal clinical benefit and increased progression to hemodialysis following endovascular intervention for atherosclerotic renal artery stenosis. Metabolic syndrome is associated with inferior early outcomes for dialysis access procedures.

摘要

代谢综合征显著增加了心血管疾病和慢性肾脏病的风险。心血管疾病风险的增加部分可能是由于腹部肥胖导致的血栓前状态。多项观察性研究一致表明,即使在调整了相关疾病后,体重指数增加、胰岛素抵抗和空腹胰岛素水平升高与慢性肾脏病有关。代谢综合征似乎是慢性肾脏病的一个危险因素,可能是由于血糖异常和高血压的共同作用。代谢综合征与血管内介入治疗粥样硬化性肾动脉狭窄后血液透析的临床获益显著降低和进展为血液透析的风险增加有关。代谢综合征与透析通路手术的早期结局较差有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e9a/3014711/ad62aad8647f/CRP2011-781035.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e9a/3014711/ad62aad8647f/CRP2011-781035.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e9a/3014711/ad62aad8647f/CRP2011-781035.001.jpg

相似文献

1
Metabolic syndrome and outcomes after renal intervention.代谢综合征与肾脏介入治疗后的结局。
Cardiol Res Pract. 2010 Dec 27;2011:781035. doi: 10.4061/2011/781035.
2
Impact of metabolic syndrome on the outcomes of percutaneous renal angioplasty and stenting.代谢综合征对经皮肾血管成形术和支架置入术治疗效果的影响。
J Vasc Surg. 2010 Apr;51(4):926-32. doi: 10.1016/j.jvs.2009.09.042.
3
Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.尿酸作为代谢综合征合并冠心病患者肾功能不全与促炎及促血栓形成状态之间的联系。
Kardiol Pol. 2011;69(4):319-26.
4
Obesity, insulin resistance and kidney disease risk: insights into the relationship.肥胖、胰岛素抵抗与肾脏疾病风险:对二者关系的见解
Curr Opin Nephrol Hypertens. 2008 Sep;17(5):450-6. doi: 10.1097/MNH.0b013e328305b994.
5
Kidney Disease in Diabetes糖尿病肾病
6
Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.腹部肥胖与代谢综合征:对全球心血管代谢风险的影响
Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1039-49. doi: 10.1161/ATVBAHA.107.159228. Epub 2008 Mar 20.
7
[Significance of the factors of hypoxia and endothelial dysfunction in kidney injury in the presence of obesity].[肥胖情况下缺氧和内皮功能障碍因素在肾损伤中的意义]
Ter Arkh. 2013;85(6):31-7.
8
Obesity, Metabolic Abnormality, and Progression of CKD.肥胖、代谢异常与 CKD 的进展。
Am J Kidney Dis. 2018 Sep;72(3):400-410. doi: 10.1053/j.ajkd.2018.02.362. Epub 2018 May 2.
9
Implications of acute functional injury following percutaneous renal artery intervention.经皮肾动脉介入术后急性功能损伤的影响
Ann Vasc Surg. 2008 Nov;22(6):783-9. doi: 10.1016/j.avsg.2008.06.006. Epub 2008 Aug 9.
10
Insulin resistance and chronic kidney disease progression, cardiovascular events, and death: findings from the chronic renal insufficiency cohort study.胰岛素抵抗与慢性肾脏病进展、心血管事件和死亡:慢性肾功能不全队列研究的结果。
BMC Nephrol. 2019 Feb 20;20(1):60. doi: 10.1186/s12882-019-1220-6.

本文引用的文献

1
Adiponectin diminishes platelet aggregation and sCD40L release. Potential role in the metabolic syndrome.脂联素可降低血小板聚集和 sCD40L 的释放。在代谢综合征中的潜在作用。
Am J Physiol Endocrinol Metab. 2010 May;298(5):E1072-7. doi: 10.1152/ajpendo.00728.2009. Epub 2010 Mar 2.
2
Impact of obesity on outcomes after open surgical and endovascular abdominal aortic aneurysm repair.肥胖对开放手术和血管内腹主动脉瘤修复术后结局的影响。
J Am Coll Surg. 2010 Feb;210(2):166-77. doi: 10.1016/j.jamcollsurg.2009.10.011. Epub 2009 Dec 24.
3
Metabolic syndrome is an independent predictor of cardiovascular events in high-risk patients with occlusive and aneurysmatic peripheral arterial disease.
代谢综合征是伴有阻塞性和动脉瘤性外周动脉疾病的高危患者心血管事件的独立预测因子。
Atherosclerosis. 2010 Jun;210(2):596-601. doi: 10.1016/j.atherosclerosis.2009.12.018. Epub 2009 Dec 22.
4
Impact of metabolic syndrome on the outcomes of percutaneous renal angioplasty and stenting.代谢综合征对经皮肾血管成形术和支架置入术治疗效果的影响。
J Vasc Surg. 2010 Apr;51(4):926-32. doi: 10.1016/j.jvs.2009.09.042.
5
Metabolic syndrome and cardiovascular risk prediction in peripheral arterial disease.代谢综合征与外周动脉疾病的心血管风险预测。
Nutr Metab Cardiovasc Dis. 2010 Nov;20(9):676-82. doi: 10.1016/j.numecd.2009.05.016. Epub 2009 Aug 20.
6
Role of adipose tissue in haemostasis, coagulation and fibrinolysis.脂肪组织在止血、凝血和纤维蛋白溶解中的作用。
Obes Rev. 2009 Sep;10(5):554-63. doi: 10.1111/j.1467-789X.2009.00593.x. Epub 2009 May 12.
7
Outcomes of endoluminal reintervention for restenosis after percutaneous renal angioplasty and stenting.经皮肾血管成形术和支架置入术后再狭窄的腔内再次干预结果。
J Vasc Surg. 2009 Apr;49(4):946-52. doi: 10.1016/j.jvs.2008.11.039. Epub 2009 Feb 14.
8
Endovascular revascularization of renal artery stenosis in the solitary functioning kidney.孤立功能肾肾动脉狭窄的血管内血运重建
J Vasc Surg. 2009 Apr;49(4):953-60. doi: 10.1016/j.jvs.2008.11.042. Epub 2009 Feb 14.
9
The influence of body mass index obesity status on vascular surgery 30-day morbidity and mortality.体重指数肥胖状态对血管外科手术30天发病率和死亡率的影响。
J Vasc Surg. 2009 Jan;49(1):140-7, 147.e1; discussion 147. doi: 10.1016/j.jvs.2008.08.052. Epub 2008 Nov 22.
10
The long-term outcomes of percutaneous therapy for renal artery fibromuscular dysplasia.经皮治疗肾动脉纤维肌发育不良的长期疗效。
J Vasc Surg. 2008 Oct;48(4):865-71. doi: 10.1016/j.jvs.2008.05.030. Epub 2008 Aug 9.